跳至主要内容
临床试验/TCTR20190728003
TCTR20190728003尚未招募未知

Effect of injected medroxyprogesterone acetate on myometrial invasion in preoperative endometrial cancer: A randomized control trial

Khon Kaen university0 个研究点目标入组 120 人开始时间: 2019年7月28日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
Female

入选标准

  • - Endometrial cancer patient
  • - Waiting for surgery more than 4 weeks

排除标准

  • 1.History of medroxyprogesterone acetate allergy
  • 2.Evidence of extrauterine cancer
  • 3.history of breast cancer
  • 4.hepatic disease
  • 5.defined as persistent systolic blood pressure > 170 mmHg or diastolic blood pressure > 110 mmHg
  • 6.osteoporosia, anorexia nervosa, rheumatoid arthritis, chronic glucocorticoid use
  • 7. Using other progesterone drugs such as contraceptive drugs, injected or IUDs within 6 weeks before diagnosed of endometrial cancer
  • 8. Venous thromboembolism;VTE
  • 9. breast mass by physical examination or abnormal mammogram

研究者

相似试验